CARISMA Therapeutics (FRA:W2J) YoY Rev. per Sh. Growth : 9.21% (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is CARISMA Therapeutics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. CARISMA Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 9.21%.

CARISMA Therapeutics's Revenue per Share for the three months ended in Mar. 2025 was €0.08.

CARISMA Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for CARISMA Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CARISMA Therapeutics YoY Rev. per Sh. Growth Chart

CARISMA Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

76.62

10.78

CARISMA Therapeutics Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial										-67.93	151.22	-17.98	-13.40	9.21

CARISMA Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

CARISMA Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2024 )
=	(Revenue per Share (A: Dec. 2024 )	-	Revenue per Share (A: Dec. 2023 ))	/	\| Revenue per Share (A: Dec. 2023 ) \|
=	(0.452	-	0.408)	/	\| 0.408 \|
=	10.78 %

CARISMA Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=	(Revenue per Share (Q: Mar. 2025 )	-	Revenue per Share (Q: Mar. 2024 ))	/	\| Revenue per Share (Q: Mar. 2024 )) \|
=	(0.083	-	0.076)	/	\| 0.076 \|
=	9.21 %

CARISMA Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of CARISMA Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

CARISMA Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARISMA Therapeutics Inc (FRA:W2J) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

CARM:USA

Address

3675 Market Street, Suite 200, Philadelphia, PA, USA, 19104

Website

https://www.carismatx.com

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

CARISMA Therapeutics Headlines

No Headlines